Programmed drug delivery system based on optimized “size decrease and hydrophilicity/hydrophobicity transformation” for enhanced hepatocellular carcinoma therapy of doxorubicin

0
20



Requirements on drug delivery systems to surmount a complex series of pathophysiological barriers bear “cascading contradictions”, especially size and hydrophilicity/hydrophobicity contradiction. Herein, a programmed drug delivery system (GNPs-Dox-Lac) based on optimized “size decrease and hydrophilicity/hydrophobicity transformation” was developed by combination the gelatin nanoparticle (GNPs) and prodrug Doxorubicin-Lactose (Dox-Lac). The results showed that GNPs-Dox-Lac (133.3 nm) were kinetically stable in blood circulation and inclined to accumulate at the tumor site.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here